India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
Why in the news? The Serum Institute of India (SII) dispatched the first set of R21/Matrix-M malaria vaccine doses to Africa, marking a significant advancement in healthcare accessibility for the continent. source:scribd About R21/Matrix-M malaria vaccine: Development and Approval: The R21/Matrix-M vaccine, developed by the University of Oxford and the Serum Institute of India, received …
Read MoreWhy in the news? Hyderabad-based Biological E initiates clinical trials for next-generation Covid vaccine targeting the XBB1.5 variant. Aimed at combating evolving strains of SARS-CoV-2, particularly amid rising cases worldwide. About India SARS-CoV-2 Genomics Consortium (INSACOG): India SARS-CoV-2 Genomics Consortium (INSACOG) initiated by the Health Ministry, DBT, CSIR, and ICMR. Consists of 54 labs monitoring …
Read MoreSyllabus: GS-3 : Women and related issues ,Present day issues and solutions , Advancement in the field of health Focus : The focus of the article is on the correlation between intimate partner violence (IPV), controlling behaviors by husbands, and the increased prevalence of sexually transmitted infections (STI) and reproductive tract infections (RTI) among Indian …
Read MoreWhy in the news? A study published in Springer Nature highlights that adolescent girls and individuals with co-morbidities are at increased risk of adverse events after receiving Bharat Biotech’s Covexin (BBV152) vaccine. Nearly one-third of participants in the observational study reported adverse events of special interest (AESI). Conducted by Banaras Hindu University, the study titled …
Read MoreSyllabus: GS-2 :Public health and expenditure by government . its impact and challenges therein. Focus : This article critically examines the trends in public health spending in India, shedding light on recent increases attributed to the States rather than the Union government. It analyzes the impact of the COVID-19 pandemic on spending patterns, explores shifts …
Read MoreDate : 14/05/2024 Syllabus: GS 2: Health Issues Relating to Development and Management of Social Sector/Services relating to Health Government Policies and Interventions for Development in various sectors Focus: The article highlights the significant milestone of 50 years of vaccination programs and their impact on global child health, particularly as new research published in The …
Read MoreWhy in the news? Safety concerns over milk products prompt Delhi High Court’s pilot project in a designated dairy, addressing spurious drugs and hygiene. About Observations on Dairy Conditions: The Delhi High Court expressed concern over the safety of milk products consumed by citizens, noting potential risks. It highlighted issues such as the use of …
Read MoreWhy in the news? AstraZeneca, known for its COVID-19 vaccine Covishield, withdraws globally due to rare side-effects and surplus availability of updated vaccines. source:reuters Key Points:AstraZeneca Withdraws COVID-19 Vaccine: AstraZeneca, in collaboration with Oxford University, has commenced the global withdrawal of its COVID-19 vaccine. Marketed as ‘Covishield’ in India through a partnership with the Serum …
Read MoreWhy in the news? West Nile fever outbreak in Kerala prompts alert after one death and eight cases reported across districts, sparking health concerns. source:scribd About Alert Issued by Kerala Government: Alert issued after one death and eight cases reported from Kozhikode, Malappuram, and Thrissur districts. Death of a 79-year-old man from Thrissur attributed to …
Read MoreSyllabus: GS 2 : Government Policies and Interventions for Development in various sectors and Issues arising out of their Design and Implementation. Issues Relating to Development and Management of Social Sector/Services relating to Health. Focus: Recent disclosures concerning AstraZeneca’s Covishield COVID-19 vaccine have sparked intense debate across various media platforms. Media outlets have reported AstraZeneca’s …
Read More
